Immune Checkpoint Inhibitors and Laryngological Outcomes in Patients with Non-Head and Neck Cancer. Dogra NS, Sataloff RT. J Voice 2026 Oct 6:S0892-1997(26)00507-2. doi: 10.1016/j.jvoice.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dogra NS, Sataloff RT. Immune Checkpoint Inhibitors and Laryngological Outcomes in Patients with Non-Head and Neck Cancer. J Voice 2026 Oct 6:S0892-1997(26)00507-2. doi: 10.1016/j.jvoice.2026.
PMID: 42838783